Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA
- PMID: 32669901
- PMCID: PMC7337250
- DOI: 10.2147/DNND.S40349
Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA
Abstract
People with neurogenic overactive bladder from either multiple sclerosis or spinal cord injury often suffer significant morbidity and decreased quality of life. Here we review the pathophysiology of neurogenic overactive bladder and the impact it can have on people with multiple sclerosis or spinal cord injury. We also address the various traditional treatment options and focus on the use of botulinum toxin A (specifically onabotulinumtoxinA) for this condition.
Keywords: multiple sclerosis; neurogenic detrusor overactivity; onabotulinumtoxinA; overactive bladder; spinal cord injury.
© 2014 Ethans et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
References
-
- Khan F, Pallant JF, Shea TL, Whishaw M. Multiple sclerosis: prevalence and factors impacting bladder and bowel function in an Australian community cohort. Disabil Rehabil. 2009;31:1567–1576. - PubMed
-
- Anderson KD. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma. 2004;21:1371–1383. - PubMed
-
- Bloemen-Vrencken JH, Post MW, Hendriks JM, De Reus EC, De Witte LP. Health problems of persons with spinal cord injury living in The Netherlands. Disabil Rehabil. 2005;27:1381–1389. - PubMed
-
- Abrams P, Cardozo L, Fall M, et al. Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–178. - PubMed
LinkOut - more resources
Full Text Sources
